391 related articles for article (PubMed ID: 28127747)
21. The vitamin D3 1alpha-hydroxylase gene and its regulation by active vitamin D3.
Takeyama K; Kato S
Biosci Biotechnol Biochem; 2011; 75(2):208-13. PubMed ID: 21307571
[TBL] [Abstract][Full Text] [Related]
22. Sphingolipids in inflammation: roles and implications.
Pettus BJ; Chalfant CE; Hannun YA
Curr Mol Med; 2004 Jun; 4(4):405-18. PubMed ID: 15354871
[TBL] [Abstract][Full Text] [Related]
23. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
24. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of vitamin D: current status.
DeLuca HF
Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
[TBL] [Abstract][Full Text] [Related]
26. Modulation of tyrosine phosphorylation signalling pathways by 1alpha,25(OH)2-vitamin D3.
Boland R; Buitrago C; De Boland AR
Trends Endocrinol Metab; 2005 Aug; 16(6):280-7. PubMed ID: 16002300
[TBL] [Abstract][Full Text] [Related]
27. Influence of dietary vitamin D3 on the circulating concentration of its active metabolites in the chick and rat.
Hughes MR; Baylink DJ; Gonnerman WA; Toverud SU; Ramp WK; Haussler MR
Endocrinology; 1977 Mar; 100(3):799-806. PubMed ID: 233823
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide and sphingolipids: mechanisms of interaction and role in cellular pathophysiology.
Perrotta C; De Palma C; Clementi E
Biol Chem; 2008 Nov; 389(11):1391-7. PubMed ID: 18783333
[TBL] [Abstract][Full Text] [Related]
29. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
30. Transformation of vitamin D3 to 1 alpha,25-dihydroxyvitamin D3 via 25-hydroxyvitamin D3 using Amycolata sp. strains.
Sasaki J; Miyazaki A; Saito M; Adachi T; Mizoue K; Hanada K; Omura S
Appl Microbiol Biotechnol; 1992 Nov; 38(2):152-7. PubMed ID: 1369418
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of 24R,25-dihydroxyvitamin D3 synthesis by metabolites of vitamin D3.
Reddy GS; Jones G; Kooh SW; Fraser D; DeLuca HF
Am J Physiol; 1983 Oct; 245(4):E359-64. PubMed ID: 6312806
[TBL] [Abstract][Full Text] [Related]
32. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
[TBL] [Abstract][Full Text] [Related]
33. Influence of calcium or 1,25-dihydroxyvitamin D3 supplementation on the hepatic microsomal and in vivo metabolism of vitamin D3 in vitamin D-depleted rats.
Haddad P; Gascon-Barré M; Brault G; Plourde V
J Clin Invest; 1986 Dec; 78(6):1529-37. PubMed ID: 3023446
[TBL] [Abstract][Full Text] [Related]
34. 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate.
Manggau M; Kim DS; Ruwisch L; Vogler R; Korting HC; Schäfer-Korting M; Kleuser B
J Invest Dermatol; 2001 Nov; 117(5):1241-9. PubMed ID: 11710939
[TBL] [Abstract][Full Text] [Related]
35. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
36. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
37. [The role of sphingolipids in selected cardiovascular diseases].
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Chabowska A; Łukaszuk B; Żendzian-Piotrowska M
Postepy Hig Med Dosw (Online); 2013 Sep; 67():1018-26. PubMed ID: 24088546
[TBL] [Abstract][Full Text] [Related]
38. Regulation of sphingosine kinase and sphingolipid signaling.
Pitson SM
Trends Biochem Sci; 2011 Feb; 36(2):97-107. PubMed ID: 20870412
[TBL] [Abstract][Full Text] [Related]
39. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.
Flanagan JN; Young MV; Persons KS; Wang L; Mathieu JS; Whitlatch LW; Holick MF; Chen TC
Anticancer Res; 2006; 26(4A):2567-72. PubMed ID: 16886665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
